Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection

Table 1 Patient characteristics and outcomes

	All patients (N = 29)	Convalescent patients (N = 26)
Age—years	57 (54–68)	37.6 (22–57)
Sex
Female	8 (27.6%)	7 (26.9%)
Male	21 (72.4%)	19 (73.1%)
BMI—kg/m²	27.9 (24.4–31.5)	N/C
Days from illness onset to first blood sampling—days	11 (9–13)	N/A
SAPS II score on day 1	27 (16–35)	N/A
SOFA score on day 1	2 (1–8)	N/A
Platelet count on day 1–10⁹/L	219 (153–260)	N/A
Lymphocyte count on day 1–10⁹/L	0.8 (0.6–1.1)	N/A
Invasive ventilation	13 (44.8%)	N/A
ARDS	14 (48.3%)	N/A
Most pathological PaO2/FiO2	156 (89–238)	N/A
Acute renal failure	8 (27.6%)	N/A
Septic shock	2 (6.9%)	N/A
Thromboembolic event	4 (13.8%)	N/A
Hospital length of stay—days	11 (7–19)	N/A
ICU length of stay—days	4 (2–13)	N/A
Hospital death	1 (3.4%)	N/A

Results are presented as n (%) or median (IQR)
BMI, body mass index; SAPS II, Simplified Acute Physiology Score II; PaO2, arterial oxygen tension; FiO2, Fraction of Inspired Oxygen
N/C: Data not collected
N/A: Not applicable

ISSN: 1743-422X